TrialAmerican journal of clinical oncology2010

Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.

Anthony P Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.